The publisher's Medical Devices sector report, “Prenatal Screening Tests - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Prenatal Screening Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Prenatal Screening Tests includes the sub-segments Free Beta Human Chorionic Gonadotropin (hCG) Tests, Pregnancy Associated Plasma Protein A (PAPP-A) Tests, Total Human Chorionic Gonadotropin (hCG) Tests, Unconjugated Estriol (uE3) Tests, Alpha-Fetoprotein (AFP) Tests and Inhibin A Tests.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Prenatal Screening Tests includes the sub-segments Free Beta Human Chorionic Gonadotropin (hCG) Tests, Pregnancy Associated Plasma Protein A (PAPP-A) Tests, Total Human Chorionic Gonadotropin (hCG) Tests, Unconjugated Estriol (uE3) Tests, Alpha-Fetoprotein (AFP) Tests and Inhibin A Tests.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Prenatal Screening Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Prenatal Screening Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Prenatal Screening Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Prenatal Screening Tests - Pipeline Products under Development by Companies
5 Prenatal Screening Companies and Product Overview
6 Prenatal Screening- Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agena Bioscience Inc
- Amity University
- Arcedi Biotech Aps
- Asuragen Inc
- BCML GmbH
- BioCeps (Inactive)
- Biocept Inc
- Biofidelity Ltd
- BioFluidica Microtechnologies LLC
- BioNano Genomics Inc
- BioReference Laboratories Inc
- Cardiff Oncology Inc
- Cellscape Corp (Inactive)
- Celula Inc
- ChromaCode Inc
- Columbia University
- Cradle Genomics Inc
- Echelon Diagnostics Inc
- ET Healthcare Inc
- Fluidigm Corp
- Fluxion Biosciences Inc
- German Cancer Research Center
- Helicos BioSciences Corporation
- iGene Laboratory Pte Ltd
- Illumina Inc
- INEX Innovate Pte Ltd
- Intignus Biotech Pvt Ltd
- Johns Hopkins University
- Juno Diagnostics Inc
- KellBenx Inc (Inactive)
- Luna Genetics Inc
- Maastricht University Medical Center
- Natera Inc
- NX Prenatal Inc.
- Oshun Medical
- Oxford Gene Technology Ltd
- Paramedical Srl
- PerkinElmer Inc
- Roche Diagnostics International Ltd
- Sequenom Inc
- Sera Prognostics Inc
- Sheba Medical Center
- Shenzhen Mindray Bio-Medical Electronics Co Ltd
- Siemens Healthcare Diagnostics Inc
- Siemens Healthineers AG
- StellarGene Technologies Pvt Ltd
- Stilla Technologies SAS
- Suzhou Basecare Medical Co Ltd
- The Chinese University of Hong Kong
- thromboDx BV
- Tufts Medical Center
- University of Cambridge
- University of Oxford
